🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A new Review in Nature Biotechnology covers epigenome editing and its versatile applications in biomedical research and disease treatment. Read the full article here: nature.com/articles/s4158…

A new retron-based method from the innovative Seth Shipman lab now allows making multiple mutations in a phage genome in a single, easy process - from point mutations to small insertions and deletions Read the overview by Ilya Osterman nature.com/articles/s4158…

I'll be attending the inaugural meeting of the iNKT community in Prague next February in representation of Nature Biotechnology. Looking forward to it!

Natural and engineered Cas12 and TnpB variants offer diverse applications in genome editing and diagnostics - read all about it in this Review in Nature Biotechnology nature.com/articles/s4158…

The program of the Consortium for iNKT Research and Therapy meeting is out: meeting2025.cirt-net.org/program.html. I will be sharing my top 10 tips on publishing with Nature Biotechnology See you there?

Nanopore technology might be able to sequence proteins soon! Read about the road ahead in this exciting Perspective rdcu.be/edWPi in Nature Biotechnology

Modulating induced proximity at the cell surface is a powerful engineering strategy that can find diverse applications in basic and translational science. Curious to learn about emerging modalities in this space? Read this review out now in Nature Biotechnology nature.com/articles/s4158…

Check out our new review on induced proximity modalities (#TPD and a lot more!) aimed cell surface targets @naturebiotech.bsky.social, spearheaded by postdocs Nick Till and Rahm Ramanathan MD, PhD nature.com/articles/s4158…

Check out the state of the field of engineered bacteria for cancer therapy in this Comment in Nature Biotechnology nature.com/articles/s4158…

Spotlight on cancer immunotherapies go.nature.com/3XUTPkM

Our poly(ester amide) work published in Nature Chemical Biology (nature.com/articles/s4158…) is highlighted in Nature Biotechnology. Engineered E. coli creates biodegradable plastics nature.com/articles/s4158…

Innate immune cells are promising candidates for cancer immunotherapy and various engineering strategies can be employed to set them up for success. Read about is in this Review in Nature Biotechnology and don't forget to check out our full Focus Issue! nature.com/articles/s4158…

Camilla Engblom and Joakim Lundeberg offer perspectives on the main opportunities and challenges to bring the current spatial transcriptomics platforms to the clinic. ➡️ nature.com/articles/s4158… #singlecell #spatialomics #spatialbiology

Cell therapies are transforming our ability to treat cancer but are out of reach for many patients. Nature Biotechnology asked experts to share their insights into pressing challenges and promising strategies to make these therapies more broadly accessible nature.com/articles/s4158…

The development of therapeutic cancer vaccines is seeing exciting progress recently. Curious how researchers are dealing with challenges to translate new technologies to the clinic? Nature Biotechnology asked experts for an update. nature.com/articles/s4158…

Will the 'skinny jabs' become known as the 'buzz killers'? GLP-1 receptor agonists have curbed some people's #addictions to #alcohol, #smoking, #cocaine, or #opioids. Research is gaining real momentum. Just out in Nature Biotechnology nature.com/articles/s4158…

New commentary in Nature Biotechnology from MD Anderson Cancer Center Dihua Yu and colleagues: Turn cold tumors hot by reprogramming the tumor microenvironment nature.com/articles/s4158…

1/ We need new ways of producing foods and fuels to minimise our impact on our planet. Our new paper now in Nature Biotechnology examines whether microbes hold the key to producing foods and fuels in the future Open access: rdcu.be/eiIUu nature.com/articles/s4158…

Christopher Voigt MIT Dept of BE MIT ChemE Dept MIT EECS Yonatan Chemla Itai Levin Environmental monitoring from the air with hyperspectral reporters #NBTNV go.nature.com/3GwRh6k

Dina Zielinski and myself analyzed the entire public financial information of @23andme to better understand the reasons behinds in down fall, which was published today at Nature Biotechnology A cautionary tale. Let dive 🧵👇